Monopar Therapeutics (MNPR) Short Interest Ratio & Short Volume $25.82 +2.03 (+8.53%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Monopar Therapeutics Short Interest DataMonopar Therapeutics (MNPR) has a short interest of 22,000 shares, representing 0.70% of the float (the number of shares available for trading by the public). This marks a -18.22% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 99,058 shares to cover all short positions.Current Short Interest22,000 sharesPrevious Short Interest26,900 sharesChange Vs. Previous Month-18.22%Dollar Volume Sold Short$495,660.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares5,278,000 sharesFloat Size3,130,000 sharesShort Percent of Float0.70%Today's Trading Volume139,033 sharesAverage Trading Volume99,058 sharesToday's Volume Vs. Average140% Short Selling Monopar Therapeutics? Sign up to receive the latest short interest report for Monopar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMNPR Short Interest Over TimeMNPR Days to Cover Over TimeMNPR Percentage of Float Shorted Over Time Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Monopar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202422,000 shares $495,660.00 -18.2%0.7%0 $22.53 11/15/202426,900 shares $486,621.00 -62.6%0.9%0 $18.09 10/31/202472,000 shares $1.05 million +44.3%3.6%0.1 $14.57 10/15/202449,900 shares $256,985.00 -55.6%2.8%0 $5.15 9/30/2024112,400 shares $757,576.00 -82.8%6.4%0.1 $6.74 9/15/2024652,500 shares $2.52 million +603.1%36.9%0.9 $3.86 Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202492,800 shares $221,792.00 +211.4%5.2%1.6 $2.39 8/15/202429,800 shares $70,626.00 -66.8%1.7%0.5 $2.37 7/31/202489,800 shares $305,769.00 +53.2%1.0%0.8 $3.41 7/15/202458,600 shares $41,606.00 -29.2%0.7%0.5 $0.71 6/30/202482,800 shares $60,452.28 -4.5%1.0%0.6 $0.73 6/15/202486,700 shares $81,498.00 +38.5%1.0%0.6 $0.94 5/31/202462,600 shares $38,254.86 -21.6%0.7%0.4 $0.61 5/15/202479,800 shares $47,728.38 -13.5%0.9%0.1 $0.60 4/30/202492,300 shares $60,927.32 -38.5%1.2%0 $0.66 4/15/2024150,000 shares $114,000.00 -12.0%2.0%0 $0.76 3/31/2024170,500 shares $116,110.50 -25.7%2.3%0 $0.68 3/15/2024229,600 shares $149,469.60 -73.0%3.6%0 $0.65 2/29/2024848,800 shares $704,504.00 +1,251.6%13.3%0.2 $0.83 2/15/202462,800 shares $21,358.28 +192.1%1.0%0 $0.34 1/31/202421,500 shares $7,213.25 -76.6%0.3%0.1 $0.34 1/15/202491,900 shares $39,939.74 -12.8%1.4%0.1 $0.43 12/31/2023105,400 shares $35,857.08 +51.4%1.7%0.1 $0.34 12/15/202369,600 shares $25,661.52 -59.0%1.1%0.1 $0.37 11/30/2023169,900 shares $50,970.00 -9.5%2.8%0.2 $0.30 11/15/2023187,800 shares $62,011.56 +277.9%3.1%0.2 $0.33 10/31/202349,700 shares $22,315.30 +7.8%0.9%0.1 $0.45 10/15/202346,100 shares $21,256.71 +27.0%0.8%0.3 $0.46 9/30/202336,300 shares $22,502.37 -43.9%0.6%0.1 $0.62 9/15/202364,700 shares $39,169.38 -33.0%1.1%0.3 $0.61 8/31/202396,600 shares $62,403.60 -65.8%1.9%0.4 $0.65 8/15/2023282,600 shares $192,168.00 +361.0%5.5%0.6 $0.68 7/31/202361,300 shares $45,423.30 +53.3%1.3%0.1 $0.74 7/15/202340,000 shares $40,000.00 -65.4%0.8%0.1 $1.00 6/30/2023115,600 shares $98,838.00 -58.6%2.4%0.4 $0.86 6/15/2023279,100 shares $235,923.23 +231.1%5.7%1 $0.85 5/31/202384,300 shares $82,445.40 +6.6%1.7%0.3 $0.98 5/15/202379,100 shares $68,026.00 +4.9%1.4%2.6 $0.86 4/30/202375,400 shares $84,832.54 +20.8%1.4%2.3 $1.13 4/15/202362,400 shares $78,761.28 -32.5%1.1%1.7 $1.2670%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << 3/31/202392,400 shares $128,445.24 +41.1%1.7%2.5 $1.39 3/15/202365,500 shares $172,265.00 +65.0%1.2%2.9 $2.63 2/28/202339,700 shares $124,261.00 +25.6%0.8%1.4 $3.13 2/15/202331,600 shares $116,920.00 -36.2%0.6%1.2 $3.70 1/31/202349,500 shares $177,210.00 +269.4%0.9%1.3 $3.58 1/15/202313,400 shares $36,602.10 +78.7%0.3%0.4 $2.73 12/30/20227,500 shares $17,775.00 -72.7%0.1%0.2 $2.37 12/15/202227,500 shares $72,875.00 -32.4%0.5%0.9 $2.65 11/30/202240,700 shares $104,599.00 +26.8%0.8%1.6 $2.57 11/15/202232,100 shares $90,201.00 +98.2%0.6%1.3 $2.81 10/31/202216,200 shares $39,852.00 +47.3%0.3%0.7 $2.46 10/15/202211,000 shares $19,800.00 -37.5%0.2%1.1 $1.80 9/30/202217,600 shares $26,752.00 +50.4%0.3%1.7 $1.52 9/15/202211,700 shares $19,072.17 +62.5%0.2%1.1 $1.63 8/31/20227,200 shares $12,960.00 +166.7%0.1%0.7 $1.80 8/15/20222,700 shares $4,995.00 -70.0%0.1%0.3 $1.85 7/31/20229,000 shares $17,640.00 +38.5%0.2%0.9 $1.96 7/15/20226,500 shares $14,625.00 -12.2%0.1%0.7 $2.25 6/30/20227,400 shares $17,019.26 +13.9%0.2%0.8 $2.30 6/15/20226,500 shares $13,325.00 -40.9%0.1%0.8 $2.05 5/31/202211,000 shares $23,540.00 +254.8%0.2%1.5 $2.14 5/15/20223,100 shares $6,262.00 -18.4%0.1%0.4 $2.02 4/30/20223,800 shares $8,664.00 +31.0%0.1%0.6 $2.28 4/15/20222,900 shares $7,192.00 -55.4%0.1%0.5 $2.48 3/31/20226,500 shares $16,575.00 +140.7%0.1%0.6 $2.55 3/15/20222,700 shares $7,317.00 -29.0%0.1%0.2 $2.71 2/28/20223,800 shares $11,742.00 -46.5%0.1%0.2 $3.09 2/15/20227,100 shares $20,803.00 -59.9%0.1%0.4 $2.93 1/31/202217,700 shares $52,215.00 -10.2%0.4%0.9 $2.95 1/15/202219,700 shares $58,312.00 -30.4%0.4%0.7 $2.96 12/31/202128,300 shares $90,843.00 -25.7%0.6%1 $3.21 12/15/202138,100 shares $146,685.00 -24.1%0.8%1.5 $3.85 11/30/202150,200 shares $220,880.00 -37.2%1.0%0.7 $4.40 11/15/202179,900 shares $388,314.00 -7.5%1.6%1.1 $4.86 10/29/202186,400 shares $414,720.00 +11.2%1.7%1.2 $4.80 10/15/202177,700 shares $381,507.00 -3.5%1.5%1 $4.91 9/30/202180,500 shares $392,035.00 -17.2%1.6%1.1 $4.87 9/15/202197,200 shares $480,168.00 +85.5%1.9%1.3 $4.94 8/31/202152,400 shares $270,908.00 -16.0%1.0%0.7 $5.17 8/13/202162,400 shares $297,024.00 -1.4%1.2%1.8 $4.76 7/30/202163,300 shares $336,123.00 -8.1%1.3%1.9 $5.31 7/15/202168,900 shares $344,500.00 -0.1%1.4%2.4 $5.00 6/30/202169,000 shares $406,410.00 +1.2%1.6%2.2 $5.89 6/15/202168,200 shares $408,518.00 +1.0%1.5%0.8 $5.99 5/28/202167,500 shares $385,425.00 -2.0%1.5%0.8 $5.71 5/14/202168,900 shares $347,945.00 +16.0%1.6%0.8 $5.05 4/30/202159,400 shares $352,836.00 +50.8%1.3%0.2 $5.94 4/15/202139,400 shares $209,608.00 +52.1%0.9%0.1 $5.32 3/31/202125,900 shares $173,530.00 +18.3%0.7%0.1 $6.70 3/15/202121,900 shares $166,440.00 +14.7%0.6%0.1 $7.6070%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << 2/26/202119,100 shares $141,149.00 -31.3%0.6%0.1 $7.39 2/12/202127,800 shares $294,680.00 +17.8%0.8%0.1 $10.60 1/29/202123,600 shares $200,836.00 -1.7%0.7%0.3 $8.51 1/15/202124,000 shares $168,240.00 -43.0%0.7%0.6 $7.01 12/31/202042,100 shares $270,282.00 +13.5%1.3%1.2 $6.42 12/15/202037,100 shares $199,969.00 +17.0%1.1%1.2 $5.39 11/30/202031,700 shares $157,866.00 -23.1%1.0%1.6 $4.98 11/15/202041,200 shares $196,112.00 -2.8%1.5%1.8 $4.76 10/30/202042,400 shares $205,640.00 +19.8%1.6%0.2 $4.85 10/15/202035,400 shares $177,354.00 -22.4%1.4%0.2 $5.01 9/30/202045,600 shares $244,078.56 -13.6%1.7%0.3 $5.35 9/15/202052,800 shares $294,624.00 -7.0%2.0%0.3 $5.58 8/31/202056,800 shares $320,920.00 +143.8%2.2%0.3 $5.65 8/14/202023,300 shares $136,072.00 +703.5%0.9%0.1 $5.84 7/31/20202,900 shares $21,286.00 -73.2%0.1%0.2 $7.34 7/15/202010,800 shares $85,752.00 +80.0%0.4%0.9 $7.94 6/30/20206,000 shares $41,400.00 +62.2%0.2%0.5 $6.90 6/15/20203,700 shares $30,414.00 +37.0%0.2%0.4 $8.22 5/29/20202,700 shares $21,303.00 +42.1%0.1%0.5 $7.89 5/15/20201,900 shares $15,010.00 -48.7%0.1%0.3 $7.90 4/30/20203,700 shares $27,232.00 +27.6%0.2%0.4 $7.36 4/15/20202,900 shares $22,243.00 -12.1%0.1%0.3 $7.67 3/31/20203,300 shares $25,707.00 +22.2%0.1%0.2 $7.79 3/13/20202,700 shares $18,387.00 -66.7%0.1%0.4 $6.81 2/28/20208,100 shares $51,759.00 -21.4%0.3%0.1 $6.39 2/14/202010,300 shares $90,022.00 -4.6%0.4%0.1 $8.74 1/31/202010,800 shares $104,328.00 +24.1%0.8%0.1 $9.66 1/15/20208,700 shares $112,491.00 +1.2%0.6%0.1 $12.93 12/31/20198,600 shares $141,900.00 No Change0.4%0.1 $16.50 MNPR Short Interest - Frequently Asked Questions What is Monopar Therapeutics' current short interest? Short interest is the volume of Monopar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 22,000 shares of MNPR short. 0.70% of Monopar Therapeutics' shares are currently sold short. Learn More on Monopar Therapeutics' current short interest. What is a good short interest percentage for Monopar Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.70% of Monopar Therapeutics' floating shares are currently sold short. Is Monopar Therapeutics' short interest increasing or decreasing? Monopar Therapeutics saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 22,000 shares, a decline of 18.2% from the previous total of 26,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Monopar Therapeutics' float size? Monopar Therapeutics currently has issued a total of 5,278,000 shares. Some of Monopar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Monopar Therapeutics currently has a public float of 3,130,000 shares. How does Monopar Therapeutics' short interest compare to its competitors? 0.70% of Monopar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Monopar Therapeutics: Phathom Pharmaceuticals, Inc. (20.55%), ProKidney Corp. (11.53%), Annexon, Inc. (6.97%), Ginkgo Bioworks Holdings, Inc. (20.44%), Astria Therapeutics, Inc. (6.53%), Humacyte, Inc. (19.60%), PureTech Health plc (0.09%), AnaptysBio, Inc. (27.33%), Mereo BioPharma Group plc (4.27%), CorMedix Inc. (11.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Monopar Therapeutics stock? Short selling MNPR is an investing strategy that aims to generate trading profit from Monopar Therapeutics as its price is falling. MNPR shares are trading up $2.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Monopar Therapeutics? A short squeeze for Monopar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MNPR, which in turn drives the price of the stock up even further. How often is Monopar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNPR, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies PHAT Short Squeeze PROK Short Squeeze ANNX Short Squeeze DNA Short Squeeze ATXS Short Squeeze HUMA Short Squeeze PRTC Short Squeeze ANAB Short Squeeze MREO Short Squeeze CRMD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNPR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNPR Stock Alerts